Drug Initiation- Major Issue In Long-Term Adherence To Medication Therapy

Published Apr 17, 2014
Gentofte, Denmark - Poor adherence to long-term medication therapy among patients with a chronic disease is well-known, but the nature of poor adherence over time, at a population level is not well established. Studies from clinical trials have shown that discontinuation is the main problem. However, everyday life differs from the structured context of a clinical trial with support around initiation and continuous follow-up. In the study, “A Multi-State Model and an Algorithm for Measuring Long-Term Adherence to Medication: A Case of Diabetes Mellitus Type 2,” researchers from Steno Diabetes Center and the Universities of Copenhagen and Southern Denmark used a new method to obtain high quality information on patient adherence behaviour over time. The objective of the study was to equip health care providers with high quality data on long-term adherence to medication to improve resource allocation and to help patients to have better adherence and thus better health outcomes. By linking two electronic registers – medical doctors’ prescriptions of Metformin and Simvastatin [to patients at Steno Diabetes Center] with type 2 diabetes; and a Danish nationwide register with registrations of medicine picked up by patients - it was possible to map patterns of adherence to medication therapy. Looking at adherence to medication over time, the study showed that those patients who wait to initiate treatment present a bigger problem than patients who do not implement a treatment dosing regimen well or who discontinue treatment early. (Adherence to medication therapy stabilized approximately one year after the prescription of medication.) According to lead author of the study, Majken Linnemann Jensen, MSc, PhD fellow, from Steno Diabetes Center and University of Copenhagen, “Discontinuation is the main driver of poor adherence to medication therapy in clinical trials. This study shows that, in a real-life setting, we need to focus more on the lack of initiation to improve adherence to medication therapy in the treatment of type 2 diabetes. This could easily be the case in other disease areas as well and should be further investigated.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Follow Value in Health on Twitter: @ISPORJournals

For more information: www.ispor.org

Related Stories

ISPOR Tackles Health Disparities with New Research Primer

Jan 22, 2025

ISPOR announced today the publication of a report from the ISPOR Health Equity Research Special Interest Group intended to establish key concepts for conducting health equity research that enables investigators to examine—and ultimately reduce—unfair social inequities in health.

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×